JFLLIFE Stock Overview
Engages in the manufacture and sale of pharmaceutical products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
JFL Life Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹63.00 |
| 52 Week High | ₹68.40 |
| 52 Week Low | ₹36.05 |
| Beta | 0 |
| 11 Month Change | 5.88% |
| 3 Month Change | 53.66% |
| 1 Year Change | 28.97% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -5.26% |
Recent News & Updates
Shareholder Returns
| JFLLIFE | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 10.4% | 1.9% | -0.6% |
| 1Y | 29.0% | 60.9% | 41.3% |
Return vs Industry: JFLLIFE underperformed the Indian Pharmaceuticals industry which returned 60.9% over the past year.
Return vs Market: JFLLIFE underperformed the Indian Market which returned 41.3% over the past year.
Price Volatility
| JFLLIFE volatility | |
|---|---|
| JFLLIFE Average Weekly Movement | 10.4% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 3.8% |
Stable Share Price: JFLLIFE's share price has been volatile over the past 3 months.
Volatility Over Time: JFLLIFE's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Smiral Patel | www.jfllifesciences.com |
JFL Life Sciences Limited engages in the manufacture and sale of pharmaceutical products in India and internationally. It offers B-Lactam dry powder injections, and solid oral dosage form tablets and capsules; general solid oral dosage form tablets and capsules; and oral rehydration solutions. The company was incorporated in 2010 and is headquartered in Ahmedabad, India.
JFL Life Sciences Limited Fundamentals Summary
| JFLLIFE fundamental statistics | |
|---|---|
| Market cap | ₹659.91m |
| Earnings (TTM) | ₹33.10m |
| Revenue (TTM) | ₹465.50m |
20.9x
P/E Ratio1.5x
P/S RatioIs JFLLIFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JFLLIFE income statement (TTM) | |
|---|---|
| Revenue | ₹465.50m |
| Cost of Revenue | ₹388.50m |
| Gross Profit | ₹77.00m |
| Other Expenses | ₹43.90m |
| Earnings | ₹33.10m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.01 |
| Gross Margin | 16.54% |
| Net Profit Margin | 7.11% |
| Debt/Equity Ratio | 16.0% |
How did JFLLIFE perform over the long term?
See historical performance and comparison